At IJISDD, the founders, investors, staff, and editorial boards all have a long-term aim to make all of science accessible to the public. This is the ethos that drives the organization. The ultimate goal is to make it possible for society to develop knowledge more expediently and effectively, which will eventually speed up innovation, health, and prosperity for everyone. The complete adoption of open access as the standard approach for publishing research findings that have been subjected to quality control will serve as the primary indicator of success. Together, we are sure that we will be able to make the future of science completely accessible and expedite the answers that we require in order to live healthy lives on a healthy planet. This confidence is a direct result of the tireless efforts of the devoted individuals who work at IJISDD, as well as the engagement of our research communities.
Original Research, Reviews, Literature Review, Conference Proceedings, Case reports, Short Communication, Thesis, Letters to the Editor, and Editorials are all types of articles that are accepted and distributed by the International Journal of In-Silico Drug Design (IJISDD). These articles include both theoretical and methodological research. In the same way as "in vivo" (in the live system) and "in vitro" (in the test tube) biological studies are analogous, the word "in silico" refers to the expansion of observations via the use of computer-based simulations and model investigations.
It is the mission of this publication to support the dissemination of cutting-edge research and updates by scientists, pharmaceutical firms, regulators, and other stakeholders who have an interest in the diagnosis, treatment, and prevention of illnesses. An open forum for the discussion, debate, and sharing of ideas about breakthroughs in the field of drug discovery is provided by the International Journal of In-Silico Drug Design (IJISDD) The scope of the magazine encompasses a broad variety of subjects, ranging from pharmacological and toxicological testing to animal research and toxicity evaluations, as well as pharmacokinetic-pharmacodynamic modeling of novel drug candidates.
IJISDD encourages submissions from scholars coming from all around the world. The creation and optimization of innovative therapies and medications should be the primary emphasis of submissions, and research should also be conducted to investigate the legislation, clinical consequences, and ethical concerns that are associated with drug development. The provision of a platform that is available to the public will contribute to the acceleration of development in the sector and bring us closer to finding remedies for diseases that pose a threat to human life.
Some Keywords: Artificial insemination, Polycystic ovarian syndrome, Implantation, IVF treatment, Experimental Design, Precision Medicine, Pharmacogenomics, Histopathology, Pharmaceutics, Medicinal Chemistry, Food Chemistry, Genotoxicity, Frozen embryo transfer, Pharmacognosy, Nuclear Pharmacy, Enzyme Inhibition, Ovulation induction, Gamete intrafallopian transfer, Antimicrobial Agents, Assisted hatching, Cheminformatics, Fertility surgery, Computational analysis, Assisted reproductive technology (ART), Cleavage stage embryo, Single embryo transfer, Network pharmacology, DNA damage and repair, Karyomapping, In vitro testing methods, In vivo animal models, Computational modeling of biological systems, Insilico drug discovery, Pharmacokinetics and pharmacodynamics modeling, Toxicology screening using Invitro methods, Molecular docking simulations, Insilico protein structure prediction, Drug design using molecular modeling, Gene expression analysis using invitro assays, Insilico screening of natural compounds, Clinical trial simulations, Drug metabolism prediction using computational models, Invitro cancer models, In vivo imaging techniques, Insilico virtual screening, Quantitative structure-activity relationship modeling, Invitro organ-on-a-chip technology, In vivo electrophysiology techniques, Insilico network analysis, Pharmacophore modeling, Invitro biomarker discovery, In vivo physiology measurements, Insilico systems biology, Protein-ligand interaction simulations, Invitro stem cell culture, In vivo immunology assays, Insilico high-throughput screening, Quantitative systems pharmacology modeling, Invitro microfluidic technology, In vivo optogenetics techniques, Insilico molecular dynamics simulations, Genome-wide association studies using invitro assays, Insilico protein-protein interaction analysis, Invitro bioassays for drug development, In vivo pharmacology studies, Insilico transcriptomics analysis, Invitro drug metabolism studies, In vivo neuroscience techniques, Insilico pathway analysis, High-content screening using Invitro methods, In vivo behavioral assays, Insilico bioinformatics analysis, Invitro epigenetic studies, Insilico homology modeling, In vivo cardiac physiology measurements, Invitro multi-omics analysis, Insilico evolutionary biology analysis, In vivo circadian rhythm studies, Insilico metabolic pathway analysis.
Keywords that are appropriate for the scope of the journal were specified; nevertheless, they were not limited to them. Please email us at info@openaccesspub.org if you have any more questions.
0 Comments